20/20 Biolabs Inc. (AIDX) vs Bio Green Med Solution, Inc. (BGMS)

A side-by-side comparison of 20/20 Biolabs Inc. and Bio Green Med Solution, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.35HealthcareDelayed quote: Oct 6, 2026, 1:23 PM EDT
Bio Green Med Solution, Inc. logo
BGMS
Bio Green Med Solution, Inc.
$5M
$0.85HealthcareDelayed quote: Oct 6, 2026, 1:18 PM EDT

Total return — AIDX vs BGMS

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)BGMS -16.5% (-16.5%/yr)BGMS compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$83
AIDX BGMS

AIDX vs BGMS: by the numbers

  • •BGMS is the larger company ($5M vs $4M market cap).
  • •Both run net losses; BGMS's is the smaller (-118.27% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXBGMS
P/S ratio2.082.52
P/B ratio2.620.66

Profitability

MetricAIDXBGMS
Gross margin31.52%19.34%
Operating margin-162.87%-1128.11%
Net margin-285.00%-118.27%
ROE-184.04%-30.74%
ROIC-116.89%-38.23%

Growth (annualized)

MetricAIDXBGMS
Revenue CAGR (5Y)-2.58%N/A

Go deeper

Full AIDX analysisFull BGMS analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEBio Green Med Solution ROE20/20 Biolabs operating marginBio Green Med Solution operating margin20/20 Biolabs revenue growthBio Green Med Solution revenue growth20/20 Biolabs free cash flowBio Green Med Solution free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.